Cargando…
IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991288/ http://dx.doi.org/10.1186/2051-1426-1-S1-P17 |
| _version_ | 1782312409511231488 |
|---|---|
| author | Johnson, C Bryce May, Bennett R Cloud, Colleen A Rubinstein, Mark P Cole, David J |
| author_facet | Johnson, C Bryce May, Bennett R Cloud, Colleen A Rubinstein, Mark P Cole, David J |
| author_sort | Johnson, C Bryce |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3991288 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39912882014-05-05 IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness Johnson, C Bryce May, Bennett R Cloud, Colleen A Rubinstein, Mark P Cole, David J J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991288/ http://dx.doi.org/10.1186/2051-1426-1-S1-P17 Text en Copyright © 2013 Johnson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Johnson, C Bryce May, Bennett R Cloud, Colleen A Rubinstein, Mark P Cole, David J IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness |
| title | IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness |
| title_full | IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness |
| title_fullStr | IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness |
| title_full_unstemmed | IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness |
| title_short | IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness |
| title_sort | il-12 primed cd8+ t-cells possess enhanced persistence and anti-tumor efficacy because of greater il-7 responsiveness |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991288/ http://dx.doi.org/10.1186/2051-1426-1-S1-P17 |
| work_keys_str_mv | AT johnsoncbryce il12primedcd8tcellspossessenhancedpersistenceandantitumorefficacybecauseofgreateril7responsiveness AT maybennettr il12primedcd8tcellspossessenhancedpersistenceandantitumorefficacybecauseofgreateril7responsiveness AT cloudcolleena il12primedcd8tcellspossessenhancedpersistenceandantitumorefficacybecauseofgreateril7responsiveness AT rubinsteinmarkp il12primedcd8tcellspossessenhancedpersistenceandantitumorefficacybecauseofgreateril7responsiveness AT coledavidj il12primedcd8tcellspossessenhancedpersistenceandantitumorefficacybecauseofgreateril7responsiveness |